Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-14 2:06 pm Purchase |
2022-12-31 | 13G | VectivBio Holding AG VECT |
Eventide Asset Management, LLC | 3,405,644 5.400% |
1,066,600![]() (+45.60%) |
Filing History |
2023-02-14 1:58 pm Sale |
2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
Eventide Asset Management, LLC | 1,032,938 2.200% |
-2,709,569![]() (-72.40%) |
Filing History |
2023-02-14 1:54 pm Purchase |
2022-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Eventide Asset Management, LLC | 394,718 9.100% |
162,341![]() (+69.86%) |
Filing History |
2023-02-14 1:48 pm Sale |
2022-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Eventide Asset Management, LLC | 2,589,778 3.700% |
-925,131![]() (-26.32%) |
Filing History |
2023-02-14 1:40 pm Purchase |
2022-12-31 | 13G | Annexon, Inc. ANNX |
Eventide Asset Management, LLC | 3,626,508 7.600% |
776,508![]() (+27.25%) |
Filing History |
2023-02-14 1:38 pm Sale |
2022-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Eventide Asset Management, LLC | 234,537 7.500% |
-19,502![]() (-7.68%) |
Filing History |
2023-02-14 1:36 pm Sale |
2022-12-31 | 13G | KnowBe4, Inc. KNBE |
Eventide Asset Management, LLC | 0 0.000% |
-4,177,983![]() (Position Closed) |
Filing History |
2023-02-14 1:34 pm Purchase |
2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Eventide Asset Management, LLC | 2,057,000 5.600% |
2,057,000![]() (New Position) |
Filing History |
2023-02-14 1:32 pm Purchase |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Eventide Asset Management, LLC | 3,150,000 6.600% |
3,150,000![]() (New Position) |
Filing History |
2023-02-14 1:30 pm Purchase |
2022-12-31 | 13G | Aura Biosciences, Inc. AURA |
Eventide Asset Management, LLC | 2,251,368 6.300% |
2,251,368![]() (New Position) |
Filing History |
2023-02-14 1:24 pm Purchase |
2022-12-31 | 13G | 908 Devices Inc. MASS |
Eventide Asset Management, LLC | 2,230,665 7.000% |
2,230,665![]() (New Position) |
Filing History |
2022-02-14 12:04 pm Purchase |
2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Eventide Asset Management, LLC | 2,629,593 7.600% |
201,617![]() (+8.30%) |
Filing History |
2022-02-14 12:01 pm Purchase |
2021-12-31 | 13G | Vital Farms, Inc. VITL |
Eventide Asset Management, LLC | 2,950,000 7.300% |
896,768![]() (+43.68%) |
Filing History |
2022-02-14 12:00 pm Purchase |
2021-12-31 | 13G | Sutro Biopharma, Inc. STRO |
Eventide Asset Management, LLC | 2,708,975 5.900% |
338,000![]() (+14.26%) |
Filing History |
2022-02-14 11:57 am Purchase |
2021-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Eventide Asset Management, LLC | 254,040 8.500% |
19,835![]() (+8.47%) |
Filing History |
2022-02-14 11:55 am Sale |
2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Eventide Asset Management, LLC | 42,499 0.100% |
-2,795,626![]() (-98.50%) |
Filing History |
2022-02-14 11:53 am Sale |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Eventide Asset Management, LLC | 138,821 0.600% |
-1,541,179![]() (-91.74%) |
Filing History |
2022-02-14 11:50 am Sale |
2021-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA |
Eventide Asset Management, LLC | 0 0.000% |
-138,000![]() (Position Closed) |
Filing History |
2022-02-14 11:47 am Purchase |
2021-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Eventide Asset Management, LLC | 232,377 9.700% |
66,667![]() (+40.23%) |
Filing History |
2022-02-14 11:46 am Purchase |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
Eventide Asset Management, LLC | 3,318,647 7.500% |
983,479![]() (+42.12%) |
Filing History |